<DOC>
	<DOCNO>NCT01215071</DOCNO>
	<brief_summary>Study mean evaluate influence different extension pelvic lymphadenectomy outcome patient bladder cancer .</brief_summary>
	<brief_title>Eingeschr√§nkte v Ausgedehnte Lymphadenektomie LEA</brief_title>
	<detailed_description>The extention pelvic lymphadenectomy surgical treatment muscle-invasive , clinically locally bladder cancer yet standardize . There data prospective study prognostic significance regional lymphadenectomy . Results retrospective study suggest , prognosis patient muscle-invasive bladder cancer improve extend limit pelvic lymphadenectomy . Furthermore could demonstrate prospective study pattern metastasis bladder cancer high variability . About two-thirds lymph node metastasis find outside normally clear area lymphadenectomy . In study patient randomize arm limited versus extend lymphadenectomy . The limited lymphadenectomy include removal obturatorical external iliac lymph node , extend one include removal lymph node pelvic floor departure inferior mesenteric artery . The primary objective study record progression-free survival . Secondary study objective include creation standard surgical treatment development quality criterion implementation international guideline . The indication adjuvant chemotherapy locally advance tumor affect .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>Histologically , muscleinvasive bladder cancer , locally completely resectable ( T2 T4a , Nx ) Age &gt; = 18 year Written consent patient Patient compliance geographic proximity allow adequate followup Histologically image diagnostics proven organ metastasis Radiographic evidence enlarge lymph node ( &gt; 1 cm ) aortic bifurcation conjunction pelvic lymph node metastasis Radiographic evidence T4btumor ( infiltration pelvic wall organ system ) Prior neoadjuvant chemotherapy bladder cancer Prior previous pelvic lymphadenectomy Prior radiotherapy pelvis internal medical anesthetic risk factor require short operation time Palliative cystectomy ( f.e . bulkydisease , infiltration adjacent structure ) Evidence another tumor restrict life expectancy patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Lymphadenectomy</keyword>
	<keyword>Extension</keyword>
	<keyword>Bladder cancer</keyword>
</DOC>